Concepedia
Statistics
Publications
7
Citations
160
H-Index
Active since
2015
Affiliations
University of Catania(Current)
Ospedale Policlinico San Martino
St. Eugenio Hospital
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Azienda ospedaliera "Bianchi-Melacrino-Morelli"
Francesco Cavazzini is an author at University of Catania specializing in pharmacology, myeloproliferative neoplasms, and medicine.
Publications per year
2015–2024
Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia
Gabriele Gugliotta, Fausto Castagnetti, M. Breccia et al. · Haematologica · 2015 · 41 citations · Full text
Medicine, Oncology, Pharmacology +10
Second primary malignancy in myelofibrosis patients treated with ruxolitinib
Nicola Polverelli, Elena Maria Elli, Elisabetta Abruzzese et al. · British Journal of Haematology · 2020 · 36 citations · Full text
Medicine, Oncology, Pharmacology +12
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real‐world data
Francesca Palandri, Massimo Breccia, Mario Tiribelli et al. · Hematological Oncology · 2020 · 23 citations · Full text
Medicine, Hematology, Pharmacology +7
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome
Francesca Palandri, Mario Tiribelli, Massimo Breccia et al. · Cancer · 2021 · 23 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +6
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib
Massimo Breccia, Daniela Bartoletti, Massimiliano Bonifacio et al. · Annals of Hematology · 2018 · 14 citations · Full text
1–5 of 7